Propelled By Increasing Adoption In Oncology Treatment, Parp Inhibitor Market Estimated To Exhibit Strong Growth
PARP (Poly ADP-ribose Polymerase) inhibitors are a class of anti-cancer drugs that help block DNA repair in cancer cells with specific deficiencies like BRCA1 and …